Literature DB >> 18772499

Estrogen-stimulated endothelial repair requires osteopontin.

Laetitia Lam Shang Leen1, Cédric Filipe, Audrey Billon, Barbara Garmy-Susini, Sandra Jalvy, Fanny Robbesyn, Danièle Daret, Cécile Allières, Susan R Rittling, Nikos Werner, Georg Nickenig, Urban Deutsch, Cécile Duplàa, Pascale Dufourcq, Françoise Lenfant, Claude Desgranges, Jean-François Arnal, Alain-Pierre Gadeau.   

Abstract

OBJECTIVE: Estradiol (E(2)) is known to accelerate reendothelialization and thus prevent intimal thickening and in-stent restenosis after angioplasty. Transplantation experiments with ERalpha(-/-) mice have previously shown that E(2) acts through local and bone marrow cell compartments to enhance endothelial healing. However, the downstream mechanisms induced by E(2) to mediate endothelial repair are still poorly understood. METHODS AND
RESULTS: We show here that after endovascular carotid artery injury, E(2)-enhanced endothelial repair is lost in osteopontin-deficient mice (OPN(-/-)). Transplantation of OPN(-/-) bone marrow into wild-type lethally irradiated mice, and vice versa, suggested that osteopontin plays a crucial role in both the local and the bone marrow actions of E(2). In the vascular compartment, using transgenic mice expressing doxycyclin regulatable-osteopontin, we show that endothelial cell specific osteopontin overexpression mimics E(2)-enhanced endothelial cell migration and proliferation in the regenerating endothelium. In the bone marrow cell compartment, we demonstrate that E(2) enhances bone marrow-derived mononuclear cell adhesion to regenerating endothelium in vivo, and that this effect is dependent on osteopontin.
CONCLUSIONS: We demonstrate here that E(2) acceleration of the endothelial repair requires osteopontin, both for bone marrow-derived cell recruitment and for endothelial cell migration and proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772499     DOI: 10.1161/ATVBAHA.108.167965

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  10 in total

1.  Activation function 2 (AF2) of estrogen receptor-alpha is required for the atheroprotective action of estradiol but not to accelerate endothelial healing.

Authors:  Audrey Billon-Galés; Andrée Krust; Coralie Fontaine; Anne Abot; Gilles Flouriot; Céline Toutain; Hortense Berges; Alain-Pierre Gadeau; Françoise Lenfant; Pierre Gourdy; Pierre Chambon; Jean-François Arnal
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

2.  Requirement of alpha(4)beta(1) and alpha(5)beta(1) integrin expression in bone-marrow-derived progenitor cells in preventing endotoxin-induced lung vascular injury and edema in mice.

Authors:  Kishore K Wary; Stephen M Vogel; Sean Garrean; Yidan D Zhao; Asrar B Malik
Journal:  Stem Cells       Date:  2009-12       Impact factor: 6.277

3.  Protection from vascular dysfunction in female rats with chronic stress and depressive symptoms.

Authors:  Steven D Brooks; Stanley M Hileman; Paul D Chantler; Samantha A Milde; Kent A Lemaster; Stephanie J Frisbee; J Kevin Shoemaker; Dwayne N Jackson; Jefferson C Frisbee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-02-16       Impact factor: 4.733

4.  Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Giuseppe Quaderno; Grazia Malaponte; Carmelo La Corte; Giuseppe Scibilia; Gabriella D'Agate; Paolo Scollo; Filippo Fraggetta; Demetrios A Spandidos; Maria Clorinda Mazzarino
Journal:  Int J Mol Med       Date:  2013-03-28       Impact factor: 4.101

5.  Expression and function of osteopontin in vascular adventitial fibroblasts and pathological vascular remodeling.

Authors:  Xin Jin; Guo-xiang Fu; Xiao-dong Li; Ding-liang Zhu; Ping-jin Gao
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

6.  CTX (crosslaps) rather than osteopontin is associated with disturbed glucose metabolism in gestational diabetes.

Authors:  Yvonne Winhofer; Florian W Kiefer; Ammon Handisurya; Andrea Tura; Katharina Klein; Barbara Schneider; Rodrig Marculescu; Oswald F Wagner; Giovanni Pacini; Anton Luger; Thomas M Stulnig; Alexandra Kautzky-Willer
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

7.  Decellularized allogeneic heart valves demonstrate self-regeneration potential after a long-term preclinical evaluation.

Authors:  Laura Iop; Antonella Bonetti; Filippo Naso; Stefania Rizzo; Stefano Cagnin; Roberto Bianco; Carlo Dal Lin; Paolo Martini; Helen Poser; Paolo Franci; Gerolamo Lanfranchi; Roberto Busetto; Michel Spina; Cristina Basso; Maurizio Marchini; Alessandro Gandaglia; Fulvia Ortolani; Gino Gerosa
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

8.  Mesangiogenic Progenitor Cells Derived from One Novel CD64(bright)CD31(bright)CD14(neg) Population in Human Adult Bone Marrow.

Authors:  Simone Pacini; Serena Barachini; Marina Montali; Vittoria Carnicelli; Rita Fazzi; Paolo Parchi; Mario Petrini
Journal:  Stem Cells Dev       Date:  2016-04-11       Impact factor: 3.272

9.  Identification of the active components in Bone Marrow Soup: a mitigator against irradiation-injury to salivary glands.

Authors:  Dongdong Fang; Shen Hu; Younan Liu; Vu-Hung Quan; Jan Seuntjens; Simon D Tran
Journal:  Sci Rep       Date:  2015-11-03       Impact factor: 4.379

10.  Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer.

Authors:  Artur Anisiewicz; Agata Pawlik; Beata Filip-Psurska; Eliza Turlej; Stanisław Dzimira; Magdalena Milczarek; Katarzyna Gdesz; Diana Papiernik; Joanna Jarosz; Dagmara Kłopotowska; Andrzej Kutner; Andrzej Mazur; Joanna Wietrzyk
Journal:  Int J Oncol       Date:  2017-11-02       Impact factor: 5.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.